Table 1.
Effect of Vigiis 101-LAB capsule I on anthropometric measurements and beneficial intestinal bacteria of healthy adults (clinical trial I).
| Treatment group | Placebo group | |||||
|---|---|---|---|---|---|---|
| Age (y) | 28.6 ± 4.2 | 28.3 ± 8.0 | ||||
| Male | 8 | 9 | ||||
| Female | 10 | 9 | ||||
| Time (Week) | Bifidobacterium spp. counts (log10 CFU/g) | Lactobacillus spp. counts (log10 CFU/g) | Bifidobacterium spp./Clostridium perfringens ratio | |||
| Placebo group | Treatment group | Placebo group | Treatment group | Placebo group | Treatment group | |
| 0 | 8.27 ± 0.40 | 8.36 ± 0.29 | 7.73 ± 0.55 | 7.71 ± 0.47 | 1.17 ± 0.08 | 1.17 ± 0.07 |
| 1 | 8.29 ± 0.42 | 8.89 ± 0.33∗ | 7.79 ± 0.40 | 8.22 ± 0.37∗ | 1.16 ± 0.08 | 1.23 ± 0.12∗ |
| 2 | 8.21 ± 0.45 | 8.78 ± 0.30∗ | 7.74 ± 0.49 | 8.42 ± 0.52∗ | 1.14 ± 0.12 | 1.22 ± 0.04∗ |
| 3 | 8.20 ± 0.39 | 8.80 ± 0.23∗ | 7.82 ± 0.41 | 8.36 ± 0.44∗ | 1.15 ± 0.09 | 1.23 ± 0.08∗ |
| 4 | 8.28 ± 0.46 | 8.98 ± 0.49∗ | 7.72 ± 0.38 | 8.44 ± 0.43∗ | 1.14 ± 0.12 | 1.25 ± 0.09∗ |
Values are mean ± SD (n = 18). ∗ Significantly different from the initial value (P < 0.05).